Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.02.2023 | Case report

Multiple drugs

Pseudomonas aeruginosa infection and resistance: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lopez-Montesinos I, et al. Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence. Antibiotics 11: 1456, No. 11, Nov 2022. Available from: URL: http://www.mdpi.com/journal/antibiotics Lopez-Montesinos I, et al. Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence. Antibiotics 11: 1456, No. 11, Nov 2022. Available from: URL: http://​www.​mdpi.​com/​journal/​antibiotics
Metadaten
Titel
Multiple drugs
Pseudomonas aeruginosa infection and resistance: case report
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-33394-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Immune-globulin

Case report

Bcg-vaccine

Case report

Multiple drugs

Case report

Tozinameran